SCHEMBL2137103

SCHEMBL2137103

COc1ccc(C(C)(C)C)c(OP(Oc2cc(OC)ccc2C(C)(C)C)Oc2cc(OC)ccc2C(C)(C)C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA12 O43570 2/20 0.45
CA7 P43166 2/20 0.45
CA9 Q16790 2/20 0.45
CA14 Q9ULX7 2/20 0.45
ALDH1A1 P00352 6/20 0.43
GAA P10253 2/20 0.43
LPAR1 Q92633 1/20 0.41
CYP1A2 P05177 5/20 0.40
CYP1A1 P04798 4/20 0.40
CYP1B1 Q16678 4/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2A6 P11509 2/20 0.37
CYP2E1 P05181 1/20 0.37
CYP2C8 P10632 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP4B1 P13584 1/20 0.37
CYP2B6 P20813 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30433720 1.00 CA1 (0.45) CA1CA2CA12CA7CA9
SCHEMBL30579954 1.00 CA1 (0.45) CA1CA2CA12CA7CA9
SCHEMBL252044 0.85 ALDH1A1 (0.54) CA1CA2CA12CA7CA9
SCHEMBL30379901 0.85 ALDH1A1 (0.54) CA1CA2CA12CA7CA9
SCHEMBL31525792 0.84 CA1 (0.58) CA1CA2CA12CA7CA9
SCHEMBL799917 0.84 CA1 (0.58) CA1CA2CA12CA7CA9
SCHEMBL9167803 0.83 CYP1A2 (0.43) CA1CA2CA12CA7CA9
SCHEMBL22140241 0.80 CA1 (0.44) CA1CA2CA12CA7CA9
Hydrochloric Acid SCHEMBL27479241 0.78 CA1 (0.45) CA1CA2CA12CA7CA9
SCHEMBL13839503 0.77 LPAR1 (0.48) ALDH1A1GAALPAR1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12202796-B2 Method for preparing 3(4),8(9)-bisformyltricyclo[5.2.1.02,6]decane SK CHEMICALS CO., LTD. (KR) 2025-01-21 US claimed
CN-112313201-B 3 (4), 8 (9) -bisformyltricyclo [5.2.1.0 2,6 ]Method for preparing decane SK化学株式会社 2023-09-15 CN claimed
US-20210253507-A1 METHOD FOR PREPARING 3(4),8(9)-BISFORMYLTRICYCLO[5.2.1.0^2,6]DECANE SK CHEMICALS CO., LTD. (KR) 2021-08-19 US claimed
EP-3808728-A1 METHOD FOR PREPARING 3(4),8(9)-BISFORMYLTRICYCLO[5.2.1.0 ²,6]DECANE SK Chemicals Co., Ltd. (KR) 2021-04-21 EP claimed
CN-112313201-A 3(4),8(9) -biscarboxyl tricyclo [5.2.1.02,6]Preparation method of decane SK化学株式会社 2021-02-02 CN claimed
US-20260035328-A1 CYCLIC DIENE-CONTAINING COMPOSITION, PRODUCTION METHOD FOR ALDEHYDE, PRODUCTION METHOD FOR ALCOHOL, AND PRODUCTION METHOD FOR CYCLIC DIENE-CONTAINING COMPOSITION MITSUBISHI CHEMICAL CORPORATION (JP) 2026-02-05 US disclosed
WO-2025057968-A1 TRICYCLODECANEDIMETHANOL COMPOSITION, UV-CURABLE COMPOSITION, POLYMER COMPOSITION, AND TRICYCLODECANEDIMETHANOL COMPOSITION PRODUCTION METHOD 三菱ケミカル株式会社 2025-03-20 WO disclosed
CN-118765270-B Tricyclodecane dimethanol composition, ultraviolet curable composition, polymer composition, and process for producing tricyclodecane dimethanol composition 三菱化学株式会社 2025-03-07 CN disclosed
US-20250026703-A1 TRICYCLODECANE DIMETHANOL COMPOSITION, ULTRAVIOLET CURABLE COMPOSITION, POLYMER COMPOSITION, AND METHOD FOR PRODUCING TRICYCLODECANE DIMETHANOL COMPOSITION MITSUBISHI CHEMICAL CORPORATION (JP) 2025-01-23 US disclosed
EP-4495096-A1 TRICYCLODECANEDIMETHANOL COMPOSITION, UV-CURABLE COMPOSITION, POLYMER COMPOSITION, AND TRICYCLODECANEDIMETHANOL COMPOSITION PRODUCTION METHOD Mitsubishi Chemical Corporation (JP) 2025-01-22 EP disclosed
US-12202796-B2 Method for preparing 3(4),8(9)-bisformyltricyclo[5.2.1.02,6]decane SK CHEMICALS CO., LTD. (KR) 2025-01-21 US disclosed
US-12180389-B2 Tricyclodecane dimethanol composition and preparation method of the same SK CHEMICALS CO., LTD. (KR) 2024-12-31 US disclosed
US-7902406-B2 Lubricating oil KYOWA HAKKO CHEMICAL CO., LTD. (JP) 2011-03-08 US disclosed
CN-101723814-A Hydroformylation process IND TECH RES INST 2010-06-09 CN disclosed
CN-101497561-A Hydroformylation process IND TECHNOLOGY RES INST TAIWAN (CN) 2009-08-05 CN disclosed
US-20090156856-A1 LUBRICATING OIL KYOWA HAKKO CHEMICAL CO., LTD. (JP) 2009-06-18 US disclosed
EP-1065194-B2 Production of tricyclodecane dicarbaldehyde, pentacyclopentadecane dicarbaldehyde and corresponding dimethanols MITSUBISHI GAS CHEMICAL CO (JP) 2007-03-28 EP disclosed
EP-1065194-B1 Production of tricyclodecane dicarbaldehyde, pentacyclopentadecane dicarbaldehyde and corresponding dimethanols MITSUBISHI GAS CHEMICAL CO (JP) 2003-05-07 EP disclosed
US-6365782-B1 HYDROFORMYLATION OF DICYCLOPENTADIENE AND/OR TRICYCLOPENTA-DIENE FOLLOWED BY HYDROGENATION; RHODIUM/ORGANOPHOSPHORUS CATALYST; SOLVENT EXTRACTION MITSBUSHI GAS CHEMICAL COMPANY, INC. (JP) 2002-04-02 US disclosed
EP-1065194-A1 Production of tricyclodecane dicarbaldehyde, pentacyclopentadecane dicarbaldehyde and corresponding dimethanols MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2001-01-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035328-A1 CYCLIC DIENE-CONTAINING COMPOSITION, PRODUCTION METHOD FOR ALDEHYDE, PRODUCTION METHOD FOR ALCOHOL, AND PRODUCTION METHOD FOR CYCLIC DIENE-CONTAINING COMPOSITION ADH1C, ADH1A, ADH5 CA1 872/4885CA2 3455/4885CA12 644/4885
US-12180389-B2 Tricyclodecane dimethanol composition and preparation method of the same DHCR7, CYP19A1, DHCR24 CA1 1414/4885CA2 3937/4885CA12 1658/4885
US-20250026703-A1 TRICYCLODECANE DIMETHANOL COMPOSITION, ULTRAVIOLET CURABLE COMPOSITION, POLYMER COMPOSITION, AND METHOD FOR PRODUCING TRICYCLODECANE DIMETHANOL COMPOSITION ERCC5, ERCC1, XPA CA1 905/4885CA2 2070/4885CA12 815/4885
US-20090156856-A1 LUBRICATING OIL ELOVL5, ACSL5, ALOX5 CA1 4039/4885CA2 4028/4885CA12 3947/4885
US-12202796-B2 Method for preparing 3(4),8(9)-bisformyltricyclo[5.2.1.02,6]decane CYP1A1, DECR1, PCBP1 CA1 4576/4885CA2 4620/4885CA12 4420/4885
US-20210253507-A1 METHOD FOR PREPARING 3(4),8(9)-BISFORMYLTRICYCLO[5.2.1.0^2,6]DECANE CYP1A1, DECR1, CYP1A2 CA1 4546/4885CA2 4346/4885CA12 4492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.